U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156500) titled 'A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone' on Aug. 28.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to evaluate the efficacy and safety of HS-20094 injection in subjects with type 2 diabetes who have inadequate glycemic control with diet and exercise alone. The primary objective of this study is to evaluate the effectiveness of HS-20094 compared to placebo in controlling blood glucose levels after 44 weeks and 52 weeks treatment.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabet...